Related Experiment Videos
Adverse reactions with methyldopa--a decade's reports
Abstract:
During 1966-75 the Swedish Adverse Drug Reaction Committee received some 300 reports of reactions to methyldopa. As the Swedish rules for reporting adverse reactions emphasize the importance of severe and unexpected reactions, the relative incidence of various adverse effects differs greatly from what would be found in an intensive study. The three most commonly reported reactions are fever, hemolysis and hepatic effects. Two-thirds of these patients were women. The median age of the groups differed, from 57 years (hepatic effects) to 69 years (hemolysis). The clinical picture of the different reactions was consistent, in the main, with what has been described previously. Between 70 and 85% of the patients in these groups were admitted to hospital because of the adverse reaction.
Insights
Adverse drug reactions to methyldopa, including fever, hemolysis, and hepatic effects, were reported in Sweden. Most affected patients were hospitalized, highlighting the severity of these methyldopa side effects.
Area of Science:
- Pharmacovigilance
- Clinical Medicine
- Drug Safety
Background:
- The Swedish Adverse Drug Reaction Committee documented approximately 300 reports of reactions to methyldopa between 1966 and 1975.
- Reporting focused on severe and unexpected adverse events, potentially skewing the observed incidence rates.
Purpose of the Study:
- To summarize and analyze reported adverse drug reactions associated with methyldopa in Sweden.
- To identify the most common adverse effects, patient demographics, and clinical outcomes.
Main Methods:
- Retrospective analysis of spontaneously reported adverse drug reactions to methyldopa.
- Categorization of reactions into fever, hemolysis, and hepatic effects.
- Demographic and clinical data extraction from case reports.
Main Results:
- Fever, hemolysis, and hepatic effects were the most frequently reported adverse reactions to methyldopa.
- The majority of affected patients were women (two-thirds).
- Median ages varied by reaction type (57 years for hepatic effects, 69 years for hemolysis).
- A significant proportion of patients (70-85%) required hospitalization due to these adverse reactions.
Conclusions:
- Methyldopa is associated with significant adverse reactions, including fever, hemolysis, and hepatic issues.
- These reactions frequently necessitate hospitalization, underscoring the need for careful patient monitoring.
- The findings are consistent with previously described clinical presentations of methyldopa toxicity.